^
BIOMARKER:

BCL2 expression

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
BCL2 expression
Diffuse Large B Cell Lymphoma
venetoclax + obinutuzumab
Sensitive: C2 – Inclusion Criteria
BCL2 expression
AML
venetoclax
Sensitive: C2 – Inclusion Criteria
BCL2 expression
HL
ABVD
Resistant: C3 – Early Trials
BCL2 expression
HL
venetoclax
Sensitive: D – Preclinical
BCL2 expression
Diffuse Large B Cell Lymphoma
venetoclax + S63845
Sensitive: D – Preclinical
BCL2 expression
Diffuse Large B Cell Lymphoma
S63845
Resistant: D – Preclinical
BCL2 expression
Multiple Myeloma
S63845
Sensitive: D – Preclinical